HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$13.44
Day range
$13.34 - $14.46
Year range
$12.12 - $35.25
Market cap
872.29M USD
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.85M | 32.10% |
Net income | -31.95M | -58.02% |
Net profit margin | — | — |
Earnings per share | -0.51 | -41.67% |
EBITDA | -41.93M | -47.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 966.57M | -5.72% |
Total assets | 1.00B | -5.65% |
Total liabilities | 44.74M | 15.51% |
Total equity | 956.82M | — |
Shares outstanding | 60.83M | — |
Price to book | 0.85 | — |
Return on assets | -10.46% | — |
Return on capital | -10.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -31.95M | -58.02% |
Cash from operations | -28.54M | -70.65% |
Cash from investing | 29.54M | -12.92% |
Cash from financing | 2.94M | -99.24% |
Net change in cash | 3.94M | -99.02% |
Free cash flow | -19.80M | -73.74% |
About
Founded
2017
Website
Employees
109
